This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 25/7/1376    most recent 01.ATV.0000168902.18672.2fv1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Honda, Y. Articles by Notake, M. Search for Related Content PubMed PubMed Citation Articles by Honda, Y. Articles by Notake, M. Pubmed/NCBI databases Medline Plus Health Information Angioplasty Related Collections Related Article

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1376.)
© 2005 American Heart Association, Inc.

Vascular Biology

A Novel vß3 Integrin Antagonist Suppresses Neointima Formation for More Than 4 Weeks After Balloon Injury in Rats

Yayoi Honda; Tomoko Kitano; Fumiyo Fukuya; Yuji Sato; Seiji Iwama; Toshiya Morie; Mitsue Notake

From the Dainippon Pharmaceutical Co., Ltd., Suita, Osaka, Japan.

Correspondence to Yayoi Honda, Pharmacology and Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, Enoki 33-94, Suita, Osaka 564-0053, Japan. E-mail yayoi-honda{at}dainippon-pharm.co.jp

Objectives— We performed a detailed kinetic analysis in a rat balloon injury model to clarify the essential roles of vß3 integrin and endothelial cell (EC) regeneration in neointima formation. Using this model, we evaluated the antistenotic effect of Dainippon compound BS-1417, a novel vß3 integrin antagonist.

Methods and Results— Kinetic analysis using RT-PCR showed that vß3 integrin-related genes are upregulated before neointima formation. Morphological and functional analyses revealed that EC regeneration requires >4 weeks after injury, and that recovery of EC normal function coincides with the arrest of neointima formation. Subcutaneous infusion of BS-1417 for 2, 4, 7, or 12 weeks after injury potently inhibited neointima formation without affecting EC regeneration. Although withdrawal of treatment with BS-1417 after short-term administration after injury resulted in catch-up growth of neointima, a long-term study suggested that this catch-up growth can be prevented by continuous administration of BS-1417 until EC regeneration.

Conclusion— We clarified that vß3 integrin and EC regeneration play an essential role in neointima formation, and that continuous administration of BS-1417 potently and stably inhibits neointima formation without affecting EC regeneration. These findings suggest that BS-1417 might be useful as a novel systemic drug for the treatment of restenosis.

We clarified the essential roles ofvß3 integrin and endothelial cell (EC) regeneration in neointima formation using a rat balloon injury model. In this model, we demonstrated that systemic administration of BS-1417, a novelvß3 integrin antagonist, potently and stably inhibits neointima formation without affecting EC regeneration.

Key Words: vß3 integrin antagonist • endothelial cell regeneration • vascular smooth muscle • gene expression • rat balloon injury model

Related Article:

Down But Not Out: New Insights Into the Role of _Vß₃ Integrins in Vascular Healing

G.A. Stouffer, A. Pathak, R. Zhao, and J. Huang
Arterioscler Thromb Vasc Biol 2005 25: 1309-1310. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				M. R. Schroeter, M. Leifheit, P. Sudholt, N.-M. Heida, C. Dellas, I. Rohm, F. Alves, M. Zientkowska, S. Rafail, M. Puls, et al. Leptin Enhances the Recruitment of Endothelial Progenitor Cells Into Neointimal Lesions After Vascular Injury by Promoting Integrin-Mediated Adhesion Circ. Res., August 29, 2008; 103(5): 536 - 544. [Abstract] [Full Text] [PDF]

				S. Jalvy, M.-A. Renault, L. L. S. Leen, I. Belloc, J. Bonnet, A.-P. Gadeau, and C. Desgranges Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration Cardiovasc Res, September 1, 2007; 75(4): 738 - 747. [Abstract] [Full Text] [PDF]

				G.A. Stouffer, A. Pathak, R. Zhao, and J. Huang Down But Not Out: New Insights Into the Role of {alpha}V{beta}3 Integrins in Vascular Healing Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1309 - 1310. [Full Text] [PDF]